Functional characterization of a rare pathogenic variant c.875G > A, p.(Cys292Tyr) in COMP.

Lan Yin, Yingchuan Zhu, Wenhao Jiang, Yue Song, Yilu Lu, Dachang Tao, Yunqiang Liu, Yongxin Ma

Journal: Annals of human genetics 2023;87(5):241-247

PMID: 37461830

Abstract

BACKGROUND

The protein encoded by the cartilage oligomeric matrix protein (COMP) gene is a noncollagenous extracellular matrix (ECM) protein that is important for chondrocyte formation and growth. Variations in the COMP gene cause pseudoachondroplasia (PSACH), which is mainly characterized by short-limbed dwarfing in the clinic.

AIMS

To characterize the function of a rare pathogenic variant in the COMP gene (c.875G > A, p.Cys292Tyr).

MATERIALS & METHODS

We performed 3D structural analysis, in vitro expression analysis, and immunofluorescence to characterize the effects of the variant on protein structure, expression, and cellular localization respectively.

RESULTS

Variation modeling showed that the interactions between amino acids were changed after the variation, and there were 31 changes in the secondary structure of mutant COMP (MT-COMP). Western blot showed that the intracellular quantity of MT-COMP was higher than the wild-type COMP (WT-COMP). Cellular immunofluorescence results showed that WT-COMP was less abundant and homogenously distributed in cells, while the MT-COMP accumulated in the cytoplasm.

DISCUSSION

Herein, we report a variant of COMP in a Chinese family with PSACH. We have shown that the rare missense variant, COMP c.875G > A, previously reported in ClinVar and identified in our patient, results in excessive accumulation of mutant protein in the cytoplasm, and is therefore pathogenic.

CONCLUSION

Through in silico and experimental analyses, we provide evidence that COMP c.875G > A is the likely cause of PSACH in a Chinese family.

© 2023 John Wiley & Sons Ltd/University College London.

Address: Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.